The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.

The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes. - The effect of postprandial hypoglycaemic agents with insulin glargine in patients with type 2 diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011793

Enrollment

Registered

2013-09-18

Start date

2011-08-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Drug administration(Insulin glargine, metoformin, miglitol, and mitiglinide)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients of 30-79 year old type 2 diabetes whose HbA1c levels are more than 7.0% with the teratment of oral hypoglyceamic agents and insulin.

Exclusion criteria

Exclusion criteria: Patients with severe liver dysfunction and renal dysfunction or type 1 diabetes.

Design outcomes

Primary

Measure	Time frame
The ahievemnt rate of taeget glucose value	—

Countries

Japan

Contacts

Public ContactNoriko Ihana

National Center for Global Health and Medicine Depertment of Diabetes, Metabolism, and Endocrinology

nori_3373@yahoo.co.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026